Kayentis Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Employees
  • 180

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $5.34M

  • Investors
  • 6

Kayentis General Information

Description

Developer of an electronic clinical outcome assessment technology designed to offer new perspectives to speed up clinical trials. The company's technology backs electronic data capture for patients in clinical trials and offers a wide range of tools that are used together and adaptable for all clinical study needs, enabling sponsors and clinical trial operators to bring simplicity to the collection of clinical trial data for both patients and sites.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 19 bis
  • Chemin du vieux Chêne
  • 38240 Meylan
  • France
+33 04
Primary Industry
Medical Records Systems
Other Industries
Practice Management (Healthcare)
Biotechnology
Vertical(s)
Corporate Office
  • 19 bis
  • Chemin du vieux Chêne
  • 38240 Meylan
  • France
+33 04

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kayentis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC 28-Mar-2023 $5.34M Completed Generating Revenue
9. Later Stage VC 02-Dec-2020 Completed Generating Revenue
8. Secondary Transaction - Private Completed Generating Revenue
7. Later Stage VC 21-Mar-2019 Completed Generating Revenue
6. Later Stage VC 17-Oct-2016 Completed Generating Revenue
5. Later Stage VC 25-Feb-2015 Completed Generating Revenue
4. Later Stage VC (Series D) 25-Oct-2013 Completed Generating Revenue
3. Later Stage VC (Series D) 10-May-2011 Completed Generating Revenue
2. Later Stage VC (Series C) 01-Sep-2007 $6.16M $9.1M Completed Startup
1. Early Stage VC (Series A) 06-Apr-2006 $2.9M $2.9M Completed Startup
To view Kayentis’s complete valuation and funding history, request access »

Kayentis Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
P shares
P shares
Series D
Series C
Series C
Preference 976,000 $0.056633 $2.38 $2.38 1x $2.38 2.93%
Ordinary 166,600 $0.056633 $2.38 $2.38 1x $2.38 0.5%
To view Kayentis’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Kayentis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an electronic clinical outcome assessment technology designed to offer new perspectives to speed up clinica
Medical Records Systems
Meylan, France
180 As of 2026

Covington, KY
 

Minnetonka, MN
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Kayentis Competitors (15)

One of Kayentis’s 15 competitors is CTI Clinical Trial and Consulting, a Private Equity-Backed company based in Covington, KY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CTI Clinical Trial and Consulting Private Equity-Backed Covington, KY
MedNet (Healthcare Technology Systems) Formerly VC-backed Minnetonka, MN
YPrime Private Equity-Backed Malvern, PA
Medidata Solutions Formerly VC-backed New York, NY
Clinical Ink Private Equity-Backed Winston-Salem, NC
You’re viewing 5 of 15 competitors. Get the full list »

Kayentis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kayentis Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innovation Capital (Private Equity) Venture Capital Minority
LBO France PE/Buyout Minority
Lenapart Venture Capital Minority
Extens Growth/Expansion Minority
Bpifrance Sovereign Wealth Fund Minority
You’re viewing 5 of 6 investors. Get the full list »

Kayentis FAQs

  • When was Kayentis founded?

    Kayentis was founded in 2005.

  • Where is Kayentis headquartered?

    Kayentis is headquartered in Meylan, France.

  • What is the size of Kayentis?

    Kayentis has 180 total employees.

  • What industry is Kayentis in?

    Kayentis’s primary industry is Medical Records Systems.

  • Is Kayentis a private or public company?

    Kayentis is a Private company.

  • What is the current valuation of Kayentis?

    The current valuation of Kayentis is .

  • What is Kayentis’s current revenue?

    The current revenue for Kayentis is .

  • How much funding has Kayentis raised over time?

    Kayentis has raised $32.3M.

  • Who are Kayentis’s investors?

    Innovation Capital (Private Equity), LBO France, Lenapart, Extens, and Bpifrance are 5 of 6 investors who have invested in Kayentis.

  • Who are Kayentis’s competitors?

    CTI Clinical Trial and Consulting, MedNet (Healthcare Technology Systems), YPrime, Medidata Solutions, and Clinical Ink are some of the 15 competitors of Kayentis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process